We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Veterinary Diagnostics Market: Growth, Size, Share, and Trends

Report Code MD 2411
Published in Oct, 2023, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Veterinary Diagnostics Market by Product (Instrument, Consumable), Technology (Immuno (ELISA, RIA, Lateral flow), Molecular (PCR, Microarray), Hematology, Imaging), Distribution Channel, End User, Unmet Need, Buying Criteria - Global Forecast to 2029

Overview

The global veterinary diagnostics market, valued at US$3.1 billion in 2022, is forecasted to grow at a robust CAGR of 7.1%, reaching US$3.3 billion in 2023 and an impressive US$5.0 billion by 2029. An increase in viral mutation rate increases the disease load on animals leading to an increase in diagnostic testing, an increase in diseases from animals that migrate from place to place, a rise in acquired ailments like dermatological diseases and urinary tract infections, a rise in animal population and a declining proper care/ hygiene, rise in pet insurance and cost of pet care, and growing demand for timely diagnostic testing for animal health, are all factors that influence this market. Untapped emerging markets hold numerous opportunities for the market to flourish. Large companies outsource manufacturing to local players, leading to opportunistic growth for local players in this market.

Veterinary Diagnostics Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Veterinary Diagnostics Market

ASIA PACIFIC:

Growth in the Asia Pacific market is driven by the growth in pet adoption, increasing awareness about animal health, and the growing per capita animal health expenditure in the region.

Growth in this market is mainly driven by the growing companion animal population, the increasing incidence of transboundary and zoonotic diseases, and the rising demand for animal-derived food products.

The European veterinary diagnostics market is expected to be worth USD 1.3 billion in 2029 growing at CAGR of 6.9% during the forecast period.

Increased adoption of pets, rise in the need for livestock and poultry products, increasing diagnostic testing in growing markets are factors influencing the market.

Shortage of veterinarians across the globe, regulatory challenges for order and sell of diagnostic kits, and lack of reimbursement despite high insurance volumes the challenges faced for the growth of the market.

Global Veterinary Diagnostics Market Dynamics

Driver: Increasing incidence of transboundary and zoonotic diseases

There are at least 30 important diseases in humans that are transmitted through animals. According to the International Livestock Research Institute (ILRI), 13 zoonoses have been identified as the cause of 2.4 billion cases of human diseases and 2.2 million deaths per year. Most human infections come from companion animals (such as dogs and cats) and livestock (such as pigs, chickens, cattle, goats, and camels). Some of the major zoonotic diseases transmitted from animals to humans are zoonotic gastrointestinal disease, leptospirosis, cysticercosis, zoonotic tuberculosis, and rabies.Toxoplasmosis, which is transmitted via cat feces and unprocessed or undercooked infected meat, is quite common, with 10–20% of the UK population and 22% of the US population expected to carry the parasite as cysts. Cats with chronic bacteremia are mainly infected through saliva; there is a high risk of transmittance from young adult cats. Although cats are asymptomatic carriers, weaker individuals can develop generalized infections. The outbreak of such diseases can affect animal health and, in the case of bovines and food-producing animals, affect meat and milk productivity and the quality of food products.

Restraint: Rising pet care costs

Veterinary spending has been exponentially growing in the last few years. The highest spending in the pet care community is taken up by pet care followed by pet food. Pet owners in the US spent over 35.9 billion dollars in the year 2022, a rise of ~15% from 2020. Pet care costs in medium sized pet care communities in veterinary practice reached up to $4,500. A rise of more than 100% in the last three years. The highest spending was up to USD 20,000. Vet visit cost has also reached a high number. Nearly 120 dollars are spent per visit to a veterinarian excluding the tests ordered for diagnosis. Nearly 160+ $ is spent on dog clinical visits and ~$75 on cat clinical visits. The rise in clinical visits is directly attributed to the increase in the cost of materials and consumables, leading to a drastic increase in clinical treatments. For instance, conducting sensitivity tests in pets using the PCR technique is more expensive than the treatment for sensitivity itself. Thus, the rise in the cost of diagnosis is a cause of concern for the growth of this market.

 

Opportunity: Untapped markets of emerging nations

A large number of revenue is expected to be generated from the emerging economies in the veterinary diagnostic market like Asia Pacific, Latin America, and Middle East and Africa. The developed regions are soon getting saturated and slow growth is observed in the emergence of newer reference labs or hospital/ clinic laboratories. This is certainly not the case in emerging economies. Here the establishment of new reference labs and improved funding at universities to conduct research for veterinary diagnostics is growing. Production of livestock and dairy products is highest in the Asian region which boosts the diagnostics market in the region. For instance, in 2022, around 55.41 million metric tons of pork was produced in China, an increase from around 52.96 million tons in the previous year. (Statista). Additionally, India is growing at a high rate in this market second to China. India is witnessing high production in dairy and meat production. For instance, in the current year 2021-22, milk production has registered an annual growth rate of5.29%. In 2021-22, the total egg production in the country is129.60 billion noswhich has increased by6.19%as compared to the previous year. The total meat production in the country is9.29 million tonnesfor the year 2021-22 with an annual growth rate of5.62%. To tackle the growing demand for animal products these countries are witnessing increased investment is observed by veterinarians into technologically advanced solutions. To increase revenue in such a high growth market, leading giants like Zoetis, Inc. are investing in the region. For instance, Zoetis, has opened a learning and training center in Thailand, to support the animal industry. Other companies like Virbac acquired Globion, an Indian organization in the animal diagnostic and treatment space.

Challenge: Developing markets are experiencing a reduction in the number of practicing veterinarians

Skilled pathologists and veterinarians are not part of the active practicing employment leading to a shortage of the total population of veterinarians in emerging economies. These economies include countries in Latin America like Brazil, Mexico, Argentina etc., some in the Asia Pacific region like India China, and others in the African region as well. This is creating a huge demand and supply gap in the veterinary profession.Every year only 3000 veterinarians graduate from colleges in India and the total. However, according to the report published by the National Sample Survey Organization (NSSO), in 2022, there is a shortage of around55,000veterinarians in India. The report also highlights the inadequate infrastructure, with only31%of the veterinary hospitals and dispensaries having the required facilities for treating animals. Additionally, the report states that around40%of the veterinary professionals in the country are not trained to handle emergencies, which is a significant concern in a sector where timely treatment can mean the difference between life and death.

Global Veterinary Diagnostics Market Ecosystem Analysis

Prominent companies in this market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific Inc. (US), bioMérieux SA (France), Heska Corporation (US), NEOGEN Corporation (US), Bio-Rad Laboratories Inc. (US), Virbac (France), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Animal Medical Technology Co. Ltd. (China), INDICAL BIOSCIENCE GmbH (Germany), BioNote, Inc. (South Korea), Biogal Galed Labs (Israel), Agrolabo S.p.A. (Italy), and Innovative Diagnostics (France)

Veterinary Diagnostics Market Ecosystem
 

The bacterial infection segment accounted for the largest share of the veterinary diagnostic industry.

Bacterial infections can be easily transmitted from one animal to another. This can happen through direct contact, through contact with contaminated surfaces or objects, or through the air. Some bacteria have developed antibiotic resistance.This means that they are no longer susceptible to the antibiotics that are commonly used to treat them. This makes treatment ineffective, and more animals are prone to bacterial infection transfer. Companion animals may also be exposed to bacteria from their humans, especially if the humans have poor hygiene. Livestock animals are often kept in close quarters, which can facilitate the spread of bacteria.Livestock animals may also be stressed, which can weaken their immune systems and make them more susceptible to infection. Such factors are responsible for its large share in the market.

The reference laboratories segment of the veterinary diagnostic industry accounted for the largest share of the end user market.

The reference laboratories segment accounted for the largest share of the veterinary diagnostic market due to the rise in the samples received by the laboratories for testing, the increase in reference laboratories in developed markets, high technological capabilities, skilled technicians, economical costs of tests and faster results, are the factors boosting the segment growth. Globally, reference laboratories are gaining greater importance due to growing concerns about animal health and the increasing prevalence of zoonotic diseases, swine flu, MERS-CoV, Ebola virus, and HIV. It has become a highly established center for the identification of various disease cases in animals like dogs, cats, sheep, goats, birds etc. The wide array of tests offered by this end user is unmatched by any other end user like a hospital or clinical lab. Some of the most prominent reference labs in developed economies are IDEXX Laboratories, Inc. (US), VCA Inc. (US), GD Animal Health (Netherlands), Zoetis, Inc. (US), NEOGEN Corporation (US), Boehringer Ingelheim (Germany), Marshfield Labs (US), ProtaTek International, Inc. (US), Texas A&M Veterinary Medical Diagnostic Laboratory (US), University of Minnesota (Veterinary Diagnostic Laboratory) (US).Molecular Diagnostics segment accounted for the highest rate in the veterinary diagnostic industry.The rise in adoption of PCR tests, increased advancements in the rPCT technology, rise in genomic testing and development of newer tests in the genomic testing segment, specificity and reliability of these tests to identify chronic conditions and cost-effectiveness influence the market growth. The rise in the number of PCR tests, such as real-time PCR, assembly PCR, hot-start PCR, methylation-specific PCR (MSP), and nested PCR, is also boosting molecular diagnostics growth due to the increased testing application for critical virus detection. Further, the RT-PCR technology is cost-effective and involves concurrent monitoring of expression levels of multiple genetic messages in real time. Additionally, the emergence of biochips and their growing applications in the identification of infectious diseases is another major factor driving microarray technology which is further responsible for boosting the molecular diagnostics market. Steady adoption of nucleic acid sequencing techniques by veterinary laboratories due to their use in identifying genomic sequencing to ease of detection of viruses, is also the factor for growth in the molecular diagnostic market.

North America Region Holds the Largest Share of the Veterinary Diagnostics Market.

The veterinary diagnostic market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & and Africa. In 2022, the North American region accounted for the largest share of the market. Factors such as increased insurance expenditure on animal health, rise in clinical and non-clinical visits to the veterinary practice, increase in private clinical practice for companion animals or equine, exponential increase in the number of households adopting pets, and a rise in number of animals in the companion segment and livestock segment.

 
 
Veterinary Diagnostics Market Region

Recent Developments of Veterinary Diagnostics Market

  • In March 2023, Zoetis, Inc. introduced two updates in the VEtscan Imagst platform. One is the AI dermatology and another for AI equine FEC analysis. These diagnostic additions broaden Vetscan Imagyst testing capabilities beyond existing AI canine and feline fecal analysis, AI blood smear analysis and digital cytology applications to include new in-clinic tests that are fully integrated into the company’s cloud-based artificial intelligence capabilities. In July 2022, BioNote USA partnered with PSIvet. The partnership will make BioNote’s Vcheck line of analyzers and tests even more affordable to PSIvet’s 5,000-plus veterinary practices.
  • In August 2021, INDICAL BIOSCIENCE acquired Checkpoints to expand its poultry portfolio and direct-to-producer offerings. In June 2021, Idexx Laboratories acquired ezyVet, a practice information management system (PIMS). The acquisition would expand Idexx’s world-class cloud software offerings that support customers with technology solutions that raise the standard of care for patients, improve practice efficiency, and enable more effective communication with pet owners.

Key Market Players

KEY PLAYERS IN THE VETERINARY DIAGNOSTICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Veterinary Diagnostics Market?

Scope of the Report

Report Attribute Details
Market Revenue Size in 2023 $3.3 billion
Projected Revenue Size by 2029 $5.0 billion
Industry Growth Rate Poised to grow at a CAGR of 7.1%
Market Driver Increasing incidence of transboundary and zoonotic diseases
Market Opportunity Untapped markets of emerging nations

Key Questions Addressed by the Report

What is the projected growth rate of the global veterinary diagnostics market between 2023 and 2029?
The global veterinary diagnostics market is projected to grow from USD 3.3 billion in 2023 to USD 5.0 billion by 2029, demonstrating a robust CAGR of 7.1%.
What are the major factors driving the veterinary diagnostics market?
The major factors include the increasing incidence of zoonotic diseases, rising pet care costs, and the growing need for timely diagnostic testing to improve animal health.
What challenges are faced by the veterinary diagnostics market?
The market faces challenges such as rising pet care costs and a shortage of skilled veterinarians in emerging markets, which can slow down market growth.
Which regions are expected to see significant growth in the veterinary diagnostics market?
Emerging regions such as Asia Pacific, Latin America, and the Middle East & Africa are expected to see significant growth due to increased investment in veterinary diagnostics and growing livestock populations.
What are the key segments of the veterinary diagnostics market?
Key segments include bacterial infection diagnostics, molecular diagnostics, and reference laboratories, with bacterial infections accounting for the largest share due to their high transmission rates.
What role do reference laboratories play in the veterinary diagnostics market?
Reference laboratories play a crucial role by offering a wide array of diagnostic tests, making them the largest end-user segment in the veterinary diagnostics market due to their high efficiency and advanced capabilities.
How does the rise in molecular diagnostics impact the veterinary diagnostics market?
The rise in molecular diagnostics, particularly PCR tests, has significantly influenced the market by improving diagnostic accuracy and enabling early detection of critical diseases in animals.
What impact do zoonotic diseases have on the veterinary diagnostics market?
Zoonotic diseases such as rabies, tuberculosis, and gastrointestinal diseases significantly drive demand for veterinary diagnostics as these diseases affect both animals and humans, increasing the need for early diagnosis.
What role does the companion animal segment play in the veterinary diagnostics market?
The companion animal segment, including dogs and cats, plays a key role in the veterinary diagnostics market due to increasing pet ownership and the growing demand for diagnostic testing for common ailments like urinary tract infections and skin diseases.
How is the North American market contributing to veterinary diagnostics?
North America accounts for the largest share of the veterinary diagnostics market due to increased spending on animal healthcare, rising pet ownership, and the presence of advanced diagnostic facilities.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Veterinary Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
40
RESEARCH METHODOLOGY
45
EXECUTIVE SUMMARY
59
PREMIUM INSIGHTS
64
MARKET OVERVIEW
68
  • 5.1 MARKET DYNAMICS
    DRIVERS
    - Growth in companion animal population
    - Rising demand for animal-derived food products
    - Increasing incidence of transboundary and zoonotic diseases
    - Rising demand for pet insurance and growing animal health expenditure
    - Growing number of veterinary practitioners and rising income levels in developed economies
    - Increasing disease control and prevention measures
    RESTRAINTS
    - Rising pet care costs
    - High cost of veterinary diagnostic tests
    OPPORTUNITIES
    - Untapped emerging markets
    CHALLENGES
    - Lack of animal healthcare awareness in emerging countries
    - Shortage of veterinary practitioners in emerging economies
  • 5.2 INDUSTRY TRENDS
    ADOPTION OF MULTIPLE TEST PANELS
    OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
    GROWING CONSOLIDATION IN VETERINARY DIAGNOSTICS INDUSTRY
    GROWING SCALE OF VETERINARY BUSINESSES
  • 5.3 DISEASE TRENDS
    LIVESTOCK
    - Avian Influenza
    - African Swine Fever
    - Bovine Babesiosis
    - Peste des Petits Ruminants
    - West Nile Virus
    COMPANION ANIMALS
    - Zoonotic diseases
    - Obesity & diabetes
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Portable instruments for POC diagnostic services
    ADJACENT TECHNOLOGIES
    - Rapid and sensitive veterinary diagnostic kits
    COMPLEMENTARY TECHNOLOGIES
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION
    AVERAGE SELLING PRICE TRENDS, BY REGION
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM/MARKET MAP
  • 5.8 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 TARIFF AND REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - US
    - Europe
    - Rest of the world
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    - North America
    - Europe
    - Rest of the world
  • 5.11 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
    JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS (2023–2025)
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.14 TRADE ANALYSIS
  • 5.15 CASE STUDIES
  • 5.16 ADJACENT MARKETS
  • 5.17 END-USER PERSPECTIVE & UNMET NEEDS
  • 5.18 AI INTEGRATION IN VETERINARY DIAGNOSTICS
VETERINARY DIAGNOSTICS MARKET, BY PRODUCT
110
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET
  • 6.3 INSTRUMENTS
    INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET
VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY
116
  • 7.1 INTRODUCTION
  • 7.2 IMMUNODIAGNOSTICS
    LATERAL FLOW ASSAYS
    - Lateral flow rapid tests
    - Lateral flow strip readers
    ELISA
    - Cost-effectiveness and ease of use to drive demand
    ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
    - Increasing incidence of allergies in companion animals to drive market growth
    IMMUNOASSAY ANALYZERS
    - Growing use of immunoassay analyzers for livestock to propel market
    RADIOIMMUNOASSAYS
    - Growing importance, high sensitivity & specificity to drive market
    OTHER IMMUNODIAGNOSTIC PRODUCTS
  • 7.3 CLINICAL BIOCHEMISTRY
    CLINICAL CHEMISTRY ANALYSIS
    - Clinical chemistry reagent clips & cartridges
    - Clinical chemistry analyzers
    GLUCOSE MONITORING
    - Blood glucose strips
    - Glucose monitors
    - Urine glucose strips
    BLOOD GAS & ELECTROLYTE ANALYSIS
    - Blood gas & electrolyte reagent clips & cartridges
    - Blood gas & electrolyte analyzers
  • 7.4 MOLECULAR DIAGNOSTICS
    PCR TESTS
    - Increased laboratory usage of PCR in proteomics and genomics to support growth
    MICROARRAYS
    - Growing applications of biochips in identifying infectious diseases to propel market
    NUCLEIC ACID SEQUENCING
    - Increased application of nucleic acid sequencing in diagnosis to drive market
    OTHER MOLECULAR DIAGNOSTIC PRODUCTS
  • 7.5 URINALYSIS
    URINALYSIS CLIPS & CARTRIDGES/PANELS
    - Growing use of clips and cartridges in urine analyzers to detect electrolytes to drive market
    URINE ANALYZERS
    - Development of easy-to-use urine analyzers for POC testing to drive market
    URINE TEST STRIPS
    - Rising occurrence of kidney diseases in cats and dogs to support market
  • 7.6 HEMATOLOGY
    HEMATOLOGY CARTRIDGES
    - Extensive use of hematology cartridges along with hematology analyzers for complete blood analysis to fuel growth
    HEMATOLOGY ANALYZERS
    - High usage of hematology analyzers by veterinary hospitals & clinics to support growth
  • 7.7 OTHER TECHNOLOGIES
VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE
161
  • 8.1 INTRODUCTION
  • 8.2 COMPANION ANIMALS
    DOGS
    - High insurance coverage for dogs to drive market
    CATS
    - Growing pet cat population to support growth
    HORSES
    - Growing equine health awareness to drive market
    OTHER COMPANION ANIMALS
  • 8.3 LIVESTOCK
    CATTLE
    - Growing consumption of meat to support market growth
    PIGS
    - Growing incidence of infectious diseases to drive market
    POULTRY
    - Increasing demand for poultry meat to contribute to market growth
    OTHER LIVESTOCK
VETERINARY DIAGNOSTICS MARKET, BY APPLICATION
180
  • 9.1 INTRODUCTION
  • 9.2 INFECTIOUS DISEASES
    BACTERIAL INFECTIONS
    - Bacterial infections to hold largest share of infectious disease diagnostics
    VIRAL INFECTIONS
    - High mutation rate to ensure continued demand for diagnostics
    PARASITIC INFECTIONS
    - High prevalence of parasitic infections to propel demand
    OTHER INFECTIONS
  • 9.3 ENDOCRINOLOGY
    GROWING RISK OF DIABETES TO SUPPORT DEMAND
  • 9.4 CARDIOLOGY
    RISING INCIDENCE OF CARDIAC DISEASES IN DOGS TO DRIVE MARKET
  • 9.5 ONCOLOGY
    HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET
  • 9.6 OTHER APPLICATIONS
VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
193
  • 10.1 INTRODUCTION
  • 10.2 DIRECT SALES
    DIRECT SALES TO HOLD LARGEST MARKET SHARE
  • 10.3 WHOLESALERS & DISTRIBUTORS
    GROWING VOLUME OF INTERNATIONAL SALES TO SUPPORT SEGMENT GROWTH
  • 10.4 ONLINE SALES PLATFORMS
    ONLINE SALES TO SEE HIGHEST GROWTH
VETERINARY DIAGNOSTICS MARKET, BY END USER
200
  • 11.1 INTRODUCTION
  • 11.2 VETERINARY REFERENCE LABORATORIES
    LARGE VOLUME OF SAMPLES RECEIVED BY VETERINARY REFERENCE LABORATORIES TO DRIVE MARKET GROWTH
  • 11.3 VETERINARY HOSPITALS & CLINICS
    GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET
  • 11.4 POC/IN-HOUSE TESTING
    EASE OF USE, COST-EFFECTIVENESS, AND SWIFT RESULTS OFFERED BY POINT-OF-CARE TESTS TO DRIVE DEMAND
  • 11.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
    INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES TO SUPPORT GROWTH
VETERINARY DIAGNOSTICS MARKET, BY REGION
207
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American market during forecast period
    CANADA
    - Growing pet adoption in Canada to drive market growth
  • 12.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising awareness of zoonotic diseases to drive market growth
    UK
    - Increasing pet ownership to drive market
    FRANCE
    - Willingness of pet owners to spend on pet health to drive market
    ITALY
    - Rising awareness about pet healthcare to propel market growth
    SPAIN
    - Growing demand for pig and poultry products to aid adoption of veterinary diagnostic products
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    CHINA
    - Large pool of food-producing animals in China to drive market
    JAPAN
    - Rising awareness about zoonotic diseases and increased pet expenditure to support adoption
    INDIA
    - Growing demand for livestock products to support market growth
    AUSTRALIA
    - Increase in pet ownership will support market growth
    SOUTH KOREA
    - Growing companion animal population to drive market
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Well-established and rapidly growing livestock industry in Brazil to promote growth
    MEXICO
    - Mexico to retain second-largest share in Latin America till 2029
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    LOW PORK PRODUCTION AND CONSUMPTION IN MIDDLE EASTERN COUNTRIES DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
401
  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.3 REVENUE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY EVALUATION MATRIX
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 13.6 START-UP/SME EVALUATION MATRIX
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    COMPETITIVE BENCHMARKING
  • 13.7 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
416
  • 14.1 KEY PLAYERS
    IDEXX LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ZOETIS, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    HESKA CORPORATION (MARS INCORPORATED)
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BIOMÉRIEUX SA
    - Business overview
    - Products/Services/Solutions offered
    - MnM view
    NEOGEN CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    VIRBAC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
    - Business overview
    - Products/Services/Solutions offered
    INDICAL BIOSCIENCE GMBH
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BIONOTE INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BIOGAL GALED LABS
    - Business overview
    - Products/Services/Solutions offered
    AGROLABO S.P.A.
    - Business overview
    - Products/Services/Solutions offered
    INNOVATIVE DIAGNOSTICS
    - Business overview
    - Products/Services/Solutions offered
  • 14.2 OTHER PLAYERS
    RANDOX LABORATORIES LTD.
    BIOCHEK
    FASSISI GMBH
    ALVEDIA
    SKYER, INC.
    SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
    PRECISION BIOSENSOR
    EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    GOLD STANDARD DIAGNOSTICS
    ANTECH DIAGNOSTICS, INC.
APPENDIX
496
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET
  • TABLE 2 NUMBER OF US HOUSEHOLDS THAT OWN A PET, BY ANIMAL TYPE (MILLIONS)
  • TABLE 3 PET POPULATION, BY ANIMAL, 2014–2022 (MILLION)
  • TABLE 4 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES
  • TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
  • TABLE 8 US: AVERAGE ANNUAL PREMIUMS PAID (2020–2022)
  • TABLE 9 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020–2022 (USD BILLION)
  • TABLE 10 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2022 (USD MILLION)
  • TABLE 11 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2020
  • TABLE 12 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS 2014 VS 2018
  • TABLE 13 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
  • TABLE 14 MAJOR ACQUISITIONS IN ANIMAL HEALTH DIAGNOSTICS INDUSTRY
  • TABLE 15 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS
  • TABLE 16 POC PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS AND MANUFACTURERS
  • TABLE 17 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2022 (USD)
  • TABLE 18 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP 3 APPLICATIONS (USD)
  • TABLE 19 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 VETERINARY DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
  • TABLE 25 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 26 TOP EXPORTERS OF VETERINARY DIAGNOSTIC CONSUMABLES (REAGENTS; COMPOSITE DIAGNOSTIC OR LABORATORY), 2022
  • TABLE 27 INCREASE IN PATIENT VISITS AND DIAGNOSTIC PROCEDURES
  • TABLE 28 UNMET CUSTOMER NEEDS IN LIVESTOCK DIAGNOSTICS MARKET
  • TABLE 29 OPPORTUNITY ASSESSMENT IN HIGH-END AUTOMATED IMMUNOASSAY ANALYZERS IN COMPANION ANIMAL IMMUNODIAGNOSTICS
  • TABLE 30 IDENTIFICATION OF INTESTINAL PARASITE
  • TABLE 31 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 32 KEY VETERINARY DIAGNOSTIC CONSUMABLES, BY COMPANY (2022)
  • TABLE 33 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 34 KEY VETERINARY DIAGNOSTIC INSTRUMENTS, BY COMPANY (2022)
  • TABLE 35 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 36 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 37 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS, BY COMPANY
  • TABLE 38 VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 39 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 40 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 41 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 42 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 43 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 44 ELISA MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 45 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 46 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 47 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 48 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 49 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS, BY COMPANY
  • TABLE 50 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 51 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 52 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 53 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 54 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 55 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 56 GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 57 GLUCOSE MONITORING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 58 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 59 GLUCOSE MONITORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 60 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 61 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 62 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 63 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 64 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 65 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 66 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 67 PCR TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 68 MICROARRAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 69 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 70 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 71 KEY VETERINARY URINALYSIS PRODUCTS, BY COMPANY
  • TABLE 72 VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 73 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 74 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 75 URINE ANALYZERS MARKET, BY COUNTRY, 2021–2029 USD MILLION)
  • TABLE 76 URINE TEST STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 77 KEY VETERINARY HEMATOLOGY PRODUCTS, BY COMPANY
  • TABLE 78 VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 79 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 80 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 81 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 82 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 83 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 84 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 85 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 86 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 87 CANINE POPULATION, BY COUNTRY, 2014–2022 (MILLION)
  • TABLE 88 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 89 FELINE POPULATION, BY COUNTRY, 2012–2020 (MILLION)
  • TABLE 90 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 91 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 92 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 93 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 94 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 95 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 96 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 97 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 98 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 99 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 100 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 101 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 102 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 103 VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 104 VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 105 VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 106 VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 107 VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 108 VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 109 VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 110 VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 111 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 112 VETERINARY DIAGNOSTICS MARKET FOR DIRECT SALES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 113 VETERINARY DIAGNOSTICS MARKET FOR WHOLESALERS & DISTRIBUTORS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 114 VETERINARY DIAGNOSTICS MARKET FOR ONLINE SALES PLATFORMS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 115 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 116 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 117 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 118 VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 119 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 120 VETERINARY DIAGNOSTICS MARKET, BY REGION, 2021–2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 133 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 138 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 139 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 140 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 VS 2021
  • TABLE 141 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
  • TABLE 142 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020
  • TABLE 143 US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 144 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 145 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 146 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 147 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 148 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 149 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 150 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 151 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 152 US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 153 US: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 154 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 155 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 156 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 157 US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 158 US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 159 US: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 160 US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 161 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 162 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 163 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 164 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 165 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 166 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 167 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 168 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 169 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 170 CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 171 CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 172 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 173 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 174 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 175 CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 176 CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 177 CANADA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 178 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 179 EUROPE: COMPANION POPULATION, 2022 (MILLION)
  • TABLE 180 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 181 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 182 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 183 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 184 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 185 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 186 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 187 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 188 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 189 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 190 EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 191 EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 192 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 193 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 194 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 195 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 196 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 197 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 198 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 199 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 200 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 201 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 202 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 203 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 204 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 205 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 206 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 207 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 208 GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 209 GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 210 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 211 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 212 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 213 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 214 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 215 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 216 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 217 UK: HOUSEHOLDS WITH PETS (2022)
  • TABLE 218 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 219 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 220 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 221 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 222 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 223 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 224 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 225 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 226 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 227 UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 228 UK: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 229 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 230 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 231 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 232 UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 233 UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 234 UK: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 235 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 236 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 237 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 238 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 239 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 240 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 241 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 242 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 243 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 244 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 245 FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 246 FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 247 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 248 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 249 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 250 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 251 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 252 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 253 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 254 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 255 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 256 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 257 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 258 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 259 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 260 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 261 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 262 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 263 ITALY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 264 ITALY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 265 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 266 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 267 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 268 ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 269 ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 270 ITALY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 271 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 272 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 273 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 274 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 275 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 276 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 277 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 278 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 279 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 280 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 281 SPAIN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 282 SPAIN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 283 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 284 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 285 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 286 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 287 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 288 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 289 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 290 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 291 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 292 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 293 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 294 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 295 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 296 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 297 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 298 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 299 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 300 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 301 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 302 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 303 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 304 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 305 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 306 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 307 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 326 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 327 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 328 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 329 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 330 CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 331 CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 332 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 333 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 334 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 335 CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 336 CHINA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 337 CHINA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 338 CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 339 CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 340 CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 341 CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 342 CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 343 CHINA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 344 CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 345 NUMBER OF DOMESTICATED DOGS AND CATS IN JAPAN, 2012–2020 (THOUSAND)
  • TABLE 346 PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 347 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 348 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 349 JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 350 JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 351 JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 352 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 353 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 354 JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 355 JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 356 JAPAN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 357 JAPAN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 358 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 359 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 360 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 361 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 362 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 363 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 364 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 365 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 366 INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 367 INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 368 INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 369 INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 370 INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 371 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 372 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 373 INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 374 INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 375 INDIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 376 INDIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 377 INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 378 INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 379 INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 380 INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 381 INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 382 INDIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 383 INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 384 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 385 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 386 AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 387 AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 388 AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 389 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 390 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 391 AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 392 AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 393 AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 394 AUSTRALIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 395 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 396 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 397 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 398 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 399 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 400 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 401 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 402 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 403 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 404 SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 405 SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 406 SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 407 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 408 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 409 SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 410 SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 411 SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 412 SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 413 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 414 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 415 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 416 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 417 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 418 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 419 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 420 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 421 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 422 REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 423 REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 424 REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 425 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 426 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 427 REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 428 REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 429 REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 430 REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 431 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 432 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 433 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 434 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 435 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 436 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 437 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 438 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2022 (MILLION)
  • TABLE 439 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)
  • TABLE 440 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 441 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 442 LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 443 LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 444 LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 445 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 446 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 447 LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 448 LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 449 LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 450 LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 451 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 452 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 453 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 455 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 458 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 459 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 460 BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 461 BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 462 BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 463 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 464 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 465 BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 466 BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 467 BRAZIL: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 468 BRAZIL: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 469 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 470 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 471 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 472 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 473 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 474 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 475 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 476 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 477 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029(USD MILLION)
  • TABLE 478 MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 479 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 480 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 481 MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 482 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 483 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 484 MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 485 MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 486 MEXICO: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 487 MEXICO: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 488 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 489 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 490 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 491 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 492 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 493 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 494 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 495 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 496 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 497 REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 498 REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 499 REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 500 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 501 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 503 REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 504 REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 505 REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 506 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 507 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 508 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 509 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 510 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 511 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 512 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 513 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 514 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION)
  • TABLE 515 MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 516 MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 517 MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 518 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 519 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 520 MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 521 MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 522 MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 523 MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION)
  • TABLE 524 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION)
  • TABLE 525 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 526 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 527 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION)
  • TABLE 528 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION)
  • TABLE 529 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION)
  • TABLE 530 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION)
  • TABLE 531 PRODUCT FOOTPRINT
  • TABLE 532 TECHNOLOGY FOOTPRINT
  • TABLE 533 END-USER FOOTPRINT
  • TABLE 534 REGION FOOTPRINT
  • TABLE 535 COMPANY FOOTPRINT
  • TABLE 536 PRODUCT LAUNCHES
  • TABLE 537 DEALS
  • TABLE 538 OTHER DEVELOPMENTS
  • TABLE 539 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 540 ZOETIS, INC.: COMPANY OVERVIEW
  • TABLE 541 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 542 HESKA CORPORATION: COMPANY OVERVIEW
  • TABLE 543 BIOMÉRIEUX SA: COMPANY OVERVIEW
  • TABLE 544 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 545 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 546 VIRBAC: COMPANY OVERVIEW
  • TABLE 547 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 548 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 549 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 550 BIONOTE INC.: COMPANY OVERVIEW
  • TABLE 551 BIOGAL GALED LABS: COMPANY OVERVIEW
  • TABLE 552 AGROLABO S.P.A.: COMPANY OVERVIEW
  • TABLE 553 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
  • FIGURE 7 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: VETERINARY DIAGNOSTICS MARKET (2022)
  • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2023–2029)
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION)
  • FIGURE 13 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023 VS. 2029 (USD MILLION)
  • FIGURE 14 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023 VS. 2029 (USD MILLION)
  • FIGURE 15 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
  • FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2029 (USD MILLION)
  • FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHICAL SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET
  • FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 20 VETERINARY REFERENCE LABORATORIES ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022
  • FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
  • FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD
  • FIGURE 23 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 MAJOR PRODUCERS OF COW MILK WORLDWIDE IN 2022, BY COUNTRY (MILLION METRIC TONS)
  • FIGURE 25 US VS CANADA: GROSS WRITTEN PREMIUMS FOR DOGS, 2020–2022 (IN USD MILLION)
  • FIGURE 26 US VS CANADA: GROSS WRITTEN PREMIUMS FOR CATS, 2020–2022 (IN USD MILLION)
  • FIGURE 27 US: PET INDUSTRY EXPENDITURE, 2010–2022
  • FIGURE 28 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2022
  • FIGURE 29 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
  • FIGURE 31 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2013-OCTOBER 2023)
  • FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013–OCTOBER 2023)
  • FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013–OCTOBER 2023)
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS
  • FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 37 VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS
  • FIGURE 38 US: NUMBER OF PRIVATE EQUINE CLINICAL PRACTICES, 2009–2022
  • FIGURE 39 MEAT PRODUCTION, BY TYPE, 2021–2022 (MILLION TONS)
  • FIGURE 40 MILK PRODUCTION, BY REGION, 2021–2022 (MILLION TONS)
  • FIGURE 41 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, EMERGING ECONOMIES VS. DEVELOPED COUNTRIES, 2020–2030
  • FIGURE 42 US: VETERINARIAN CLINICAL PRACTICES, BY TYPE, 2022
  • FIGURE 43 NORTH AMERICA: PROJECTED GROWTH IN NUMBER OF VETERINARIANS
  • FIGURE 44 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 45 US: POPULATION OF DOGS, 2012–2022 (MILLION)
  • FIGURE 46 US: EXPENDITURE ON VET VISITS, 2013–2021
  • FIGURE 47 US: VETERINARIAN INCOME LEVELS, 2017–2022
  • FIGURE 48 US: NUMBER OF VETERINARIANS, 2016–2021
  • FIGURE 49 CANADA: COMPANION ANIMAL POPULATION, 2020–2022 (MILLION)
  • FIGURE 50 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 51 JAPAN: FOOD, SNACK, AND MEDICAL EXPENDITURE FOR CATS AND DOGS (USD)
  • FIGURE 52 REVENUE ANALYSIS FOR KEY COMPANIES IN PAST FIVE YEARS
  • FIGURE 53 VETERINARY DIAGNOSTICS MARKET: MARKET SHARE ANALYSIS, 2022
  • FIGURE 54 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022
  • FIGURE 55 VETERINARY DIAGNOSTICS MARKET: START-UP/SME EVALUATION MATRIX (2022)
  • FIGURE 56 IDEXX LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 57 ZOETIS, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 58 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (20222)
  • FIGURE 59 HESKA CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 60 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
  • FIGURE 61 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 63 VIRBAC: COMPANY SNAPSHOT (2022)
  • FIGURE 64 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 65 MINDRAY GROUP: COMPANY SNAPSHOT (2022)

The study involved four major activities in estimating the current size of the veterinary diagnostic market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary sources referred to for this research study include financial statements of companies offering microfluidics and information from various trade, business, and professional associations. The secondary data was collected and analyzed to arrive at the overall size of the Veterinary Diagnostic Market, which was validated by primary respondents.

Primary Research

Extensive primary research was conducted after obtaining information regarding the Veterinary Diagnostic Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific,  Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from microfluidics manufacturers; distributors; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using microfluidics were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of veterinary diagnostics and the future outlook of their business, which will affect the overall market.

Breakdown of Primary Interviews : Supply-Side Participants, By Company Type, Designation, and Region

Veterinary Diagnostic Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the veterinary diagnostic market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the veterinary diagnostic market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall veterinary diagnostic market was obtained from secondary data and validated by primary participants to arrive at the total veterinary diagnostic market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Veterinary Diagnostic Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Veterinary Diagnostic Market Size: Top-Down Approach

Veterinary Diagnostic Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Veterinary Diagnostic Market Size: Bottom-Up Approach

Veterinary Diagnostic Market Size, and Share

Data Triangulation

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

Veterinary diagnostics refers to the diagnosis of animal diseases and disorders using various veterinary diagnostic test kits, tools, and instruments such as clinical chemistry analyzers, hematology analyzers, glucose monitoring systems, urine analyzers, blood gas-electrolyte analyzers, and ELISA test kits.

Instruments used for veterinary diagnostics are analyzers such as Idexx Catalyst One, VetTest Chemistry Analyser, Heska Element DC Chemistry Analyser, Element POC Blood Gas & Electrolyte Analyser, Randox Laboratories  RX Monza Veterinary Immunoassay Analyzer, etc. And consumables are used to run the test more efficiently such as controls, reagents, clips, cartridges, test strips, etc. Certain examples of the consumables used in the diagnosis of various diseases include Thermofisher VetMAX African Swine Fever Detection Kit, PrioCHECK FMDV Type A Antibody ELISA Kit, Bovine Viral Diarrhea PCR Detection Kit, Anti-Rabies Nucleocapsid Conjugate, etc. Veterinary diagnostic tests are mainly ordered by the veterinarian to identify parasites, bacteria, viruses, and other disease-causing microbes in companion animals or livestock. Improvements in consumables enable precise detection despite limitations observed by other tests. For instance, a diagnostic test using a new improved fecal detection test kit by Idexx laboratories eliminates the limitations of egg shedding identification and reduces false positive cases in the diagnosis of hookworm antigens in the companion animal intestine. Thus, veterinary diagnostic tests are ordered for all kinds of ailments to enable effective detection and help in treatment planning and decision making by the veterinarian and the companion animal owner.

Key Stakeholders

  • Senior Management
  • Lab Technicians/Veterinary Doctors
  • Finance/Procurement Department

Report Objectives

  • To define, describe, and forecast the veterinary diagnostic market by product, technology, animal type, distribution channel, application, end user, and region.
  • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
  • To strategically analyze the regulatory scenario, Porter’s five force analysis, value chain analysis, supply chain analysis, ecosystem map, recession impact, and patent analysis
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary diagnostic market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
  • To strategically analyze the veterinary diagnostic market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as acquisitions, product launches, partnerships, and expansions in the veterinary diagnostic market

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Europe Veterinary Diagnostic Market into the Netherlands, Austria, Belgium, and others
  • Further breakdown of the Rest of Asia Pacific Veterinary Diagnostic Market into Singapore, Malaysia, and others

Company Information

  • Detailed analysis and profiling of additional market players

Previous Versions of this Report

Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarrays), Hematology), Animal (Dogs, Cats, Cattle, Pigs), End User (Hospitals & Clinics) - Global Forecast to 2027

Report Code MD 2411
Published in Sep, 2022, By MarketsandMarkets™

Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, Hematology, Urinalysis), Animal (Dog, Cat, Cattle, Pig, Poultry, Horse), End User - Global Forecast to 2026

Report Code MD 2411
Published in Jun, 2021, By MarketsandMarkets™

Veterinary Diagnostics Market by Product (Instruments, Consumables),Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, Molecular Diagnostics), Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry), End User - Global Forecast to 2023

Report Code MD 2411
Published in Jul, 2018, By MarketsandMarkets™

Veterinary Diagnostics Market by Product (Instruments and Consumables), Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, and Molecular Diagnostics), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, and Poultry), and End User - Global Forecast to 2022

Report Code MD 2411
Published in Apr, 2017, By MarketsandMarkets™

Veterinary Diagnostics Market by Product (Instruments, Consumables, Services) by Technology (Diagnostic Imaging, Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics) by Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry) - Global forecast to 2021

Report Code MD 2411
Published in Apr, 2016, By MarketsandMarkets™

Veterinary Diagnostics Market by Products (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging), by Animals (Companion, Food-producing, Dog, Livestock, Poultry, Swine) - Global Forecast to 2018

Report Code MD 2411
Published in Apr, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Veterinary Diagnostics Market

John

Jun, 2022

Which is the leading segment dominating the Veterinary Diagnostics Market?.

Jeremy

Jun, 2022

Can you give some more information on the key factors impacting the Veterinary Diagnostics Market?.

John

Jun, 2022

Which are the latest trends to focus for revenue expansion in Veterinary Diagnostics Market?.

©2025 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status